Efficacy of oral calcium and/or sodium phosphate in the prevention of parturient paresis in cows

The goal of this study was to investigate the efficacy of calcium chloride, sodium phosphate or a combination of these two substances administered orally immediately postpartum for the prevention of parturient paresis in cows. Thirty-two cows that had had parturient paresis at the previous calving, and in which serum biochemistry had shown hypocalcaemia and hypophosphataemia, were used in the study. The cows were transferred to the Department of Farm Animals, University of Zurich, five days before their expected due dates. On a randomized trial, the cows were given calcium chloride, sodium phosphate, both substances or no treatment (controls) via a stomach tube immediately postpartum and 12 hours later. The cows were monitored for 96 hours during which time blood was collected on a regular basis for the determination of total calcium, ionized calcium, inorganic phosphorus and magnesium concentrations. Of the 32 cows treated, 19 (59%) had parturient paresis and 13 (41%) did not. The incidence of parturient paresis did not differ significantly among the groups although there was a tendency for a lower incidence in cows treated with both calcium chloride and sodium phosphate. The various treatments had no apparent effect on serum calcium concentration. The concentration of inorganic phosphorus increased significantly in cows treated with sodium phosphate compared with the controls. The results of this study showed that cows treated with both calcium chloride and sodium phosphate orally tended to have a lower incidence of parturient paresis. Further investigation into multiple administrations of oral calcium chloride and sodium phosphate, started before parturition, for the prevention of parturient paresis is required.     

Effect of intravenous calcium and oral sodium phosphate in cows with parturient paresis

The goal of this study was to determine whether oral administration of sodium phosphate in conjunction with intravenous calcium is more efficaceous than intravenous calcium alone for the treatment of parturient paresis. Thirty cows with parturient paresis were examined and treated by the same veterinarian. The cows were divided randomly into two groups of 15 cows each. Cows in group A received 500 ml of a 40 per cent calcium borogluconate solution containing 15.65 g calcium gluconate and borogluconate, with a supplement of 6 per cent magnesium hypophosphite (9.85 g magnesium hypophosphite) intravenously over a period of approximately 15 min. Cows in group B received the same treatment as well as 350 g of monobasic sodium phosphate (70 g inorganic phosphate, NaH2PO4 2 H2O, Streuli) dissolved in 0.5 litres of distilled water orally via a stomach tube. After treatment, the heart rate, respiratory rate, rectal temperature, superficial body temperature, rumen motility, appetite and defecation of the cows were monitored every hour for eight h. The cows' attempts to rise and their ability to stand were also noted. Initially, the results of clinical examination and serum electrolyte analyses did not differ between the two groups of cows.Within one hour of treatment, stupor was not observed in any of the cows. The general demeanour after treatment did not differ significantly between the two groups. In both groups, the average rectal temperature increased within two hours of the initiation of treatment, from 38.0 +/- 0.95 degrees C to 38.5 +/- 0.40 degrees C. There was no significant difference in the recovery rate between the groups. Of the 30 cows, 22 (73.3 per cent) stood within eight hours of treatment (10 cows from group A and 12 cows from group B). The type of treatment did not affect the time required to stand: cows in group A stood within 47.3 +/- 44 minutes and cows in group B stood within 24.2 +/- 32 minutes after the start of treatment. Our findings do not support the hypothesis that oral treatment with 350 g of sodium phosphate together with intravenous infusion of calcium in cows with parturient paresis results in an improved outcome, even though all the cows had hypophosphataemia as well as hypocalcaemia.     

Effects of long-term dietary supplementation with clinoptilolite on incidence of parturient paresis and serum concentrations of total calcium, phosphate, magnesium, potassium, and sodium in dairy cows

OBJECTIVE: To determine whether dietary supplementation with clinoptilolite affects the incidence of parturient paresis and serum concentrations of total calcium (tCa), inorganic phosphorus (PO(4) (2)), magnesium (Mg2+), potassium (K+), and sodium (Na+) in dairy cattle. ANIMALS: 52 dairy cows. Procedure-Cows were placed into 3 groups. The first 2 groups (group A [n = 17] and group B [17]) were offered a concentrate supplemented with 1.25% and 2.5% clinoptilolite, respectively. The third (group C [n = 18]) served as a control and was offered the concentrate alone. The experiment started 1 month before parturition and lasted until the beginning of the next nonlactating period. Around the time of calving, all cows were monitored for the development of parturient paresis. Blood samples were taken at the commencement of the experiment, on the day of calving, and thereafter at monthly intervals to measure serum tCa, PO(4) (2), Mg2+, K+, and Na+ concentrations. Results-The incidence of parturient paresis in group B cows was significantly lower, compared with group C cows. However, serum concentrations of tCa, P(O4) (2), Mg2+, K+, and Na+ were not significantly affected by long-term supplementation with clinoptilolite. CONCLUSIONS AND CLINICAL RELEVANCE: In the context of this experiment, clinoptilolite supplementation at 2.5% appeared to have reduced the incidence of parturient paresis in dairy cows, suggesting that its effectiveness depends on the amount incorporated in the ration of cows. Addition of clinoptilolite in the concentrate of dairy cows during the nonlactating period could be used as a cost-effective preventive treatment for parturient paresis.     

Treatment of cows with milk fever using intravenous and oral calcium and phosphorus

Fifteen cows with milk fever were treated with 500ml of 40 % calcium borogluconate (group A) administered intravenously. Fifteen other cows with milk fever received the same treatment, supplemented with 500ml of 10 % sodium phosphate administered intravenously, and 80g calcium as calcium lactate and 70g inorganic phosphorus as sodium phosphate administered orally in drinking water. The cows were monitored and blood samples collected for 3 days to measure the concentrations of total and ionized calcium, inorganic phosphorus and magnesium and the activity of creatine kinase. The two groups did not differ significantly with respect to the course of the disease. In each group 14 cows were cured. A rapid and significant increase in serum calcium concentration from the hypo- to the hypercalcaemic range occurred in both groups within 10min of the start of treatment, followed by a slow and steady decrease to the hypocalcaemic range. Calcium lactate did not prevent the calcium concentration from returning to the hypocalcaemic range, and the calcium profiles of the two groups did not differ significantly. As expected, treatment had little effect on the concentration of inorganic phosphorus in group A. In group B, treatment caused a rapid increase in the concentration of inorganic phosphorus to a maximum 20min after the start of treatment. This was followed by a slow decrease in the phosphorus concentration to the normophosphataemic range. Our findings confirmed that combined intravenous and oral administration of sodium phosphate in cows with periparturient paresis attributable to hypocalcaemia and hypophosphataemia results in a rapid and sustained increase in serum phosphorus, but not in serum calcium concentration. This modified therapy did not improve the success rate of milk fever treatment and further studies are needed to improve treatment of periparturient paresis.     

Interaction between the levels of hormones and minerals in sera of healthy and sick cows

An interaction between blood levels of parathyroid hormone, calcitonin, 1.25-dihydroxycholecalciferol and levels of calcium, phosphorus and magnesium was examined in 85 cows, which included healthy cows and cows with ostemalacia, mastitis and paresis. Levels of parathyroid hormone (PTH) and calcitonin were determined in vitro using IMMULITE analyser (Diagnostic Products Corporation, USA), by means of immunometric assay. Levels of vitamin D were measured using the enzyme linked immunosorbent assay (ELISA). Levels of calcium, phosphorus and magnesium were determined using the automated Eos-Bravo analyser (Hospitex Diagnostics, Italy) with HOSPITEX reagents. The lowest blood levels of calcium (1.38 +/- 0.18 mmol/L) and phosphorus (0.65 +/- 0.12 mmol/L) were found in cows with parturient paresis. Decreased blood levels of phosphorus and magnesium were also determined in cows with osteomalacia. For cows with parturient paresis, which received a mineral supplement, the average serum level of calcium was by 20.7% higher than the level found in those which did not receive a supplement, and the level of phosphorus was by 23.6% higher, however, these levels remained low. The blood level of parathyroid hormone ranged from 3.47 to 5.20 pmol/L in healthy cows and from 3.95 to 15.21 pmol/L in sick cows. The highest and statistically significant increase in blood PTH level (up to 18.31 +/- 1.88 pmol/L) was found in cows with parturient paresis. The blood level of PTH correlated inversely with the level of calcium in cows with osteomaliacia (r = -0.89) and in cows with parturient paresis (r = -0.49 and r = -0.61, respectively). The serum level of calcitonin ranged from 1.46 pmol/L to 2.40 pmol/L in healthy and sick cows and the difference was not statistically significant. Lower serum levels of vitamin D were found in heifers-in-calf and in cows with mastitis. A clear correlation between levels of calcitonin, vitamin D and macronutrients was not found.     

Treatment of parturient paresis with high-dose calcium

The goal of the present study was to evaluate a calcium dose that was higher than the conventional dose for treatment of parturient paresis in cows. Thirty cows with parturient paresis received 1000 ml of 40 per cent calcium borogluconate solution supplemented with 6 per cent magnesium hypophosphite. Cows in group A received 200 ml of the solution intravenously over a 10-minute period, and the remaining 800 ml via a slow intravenous drip over a six-hour period. Cows in group B received 500 ml of the solution intravenously over a 20-minute period, and the remaining 500 ml via a slow intravenous drip over a six-hour period. Afterwards, the cows were monitored continuously and examined every hour for eight hours. Samples of blood were collected from all the cows before treatment and at 10, 20, 40, 60, 90, 120, 180, 240, 300, 360, 420 and 480 minutes and 24, 48 and 72 hours after treatment. The concentrations of total calcium, ionised calcium, inorganic phosphorus and magnesium were determined. Cows that did not stand within 12 hours of treatment received one or more additional treatments. There was no significant difference in the recovery rate between the two groups. Of the 30 cows, 14 (47 per cent) rised after one treatment and 15 others (50 per cent) were cured after two or more treatments. One cow did not respond to repeated treatments and was euthanased four days after the start of treatment. The results of electrolyte analyses before treatment did not differ significantly between the two groups. In 27 (90 per cent) cows, the concentrations of calcium and inorganic phosphorus were lower than normal and in 3 (10 per cent) cows, only the concentration of inorganic phosphorus was lower than normal.The concentration of total calcium increased markedly ten minutes after the start of treatment in both groups, and at eight hours, the mean concentration of calcium was within the normal range. At 24 and 48 hours, the mean concentration of calcium was below normal, but at 72 hours it was again within the normal range. The concentration of inorganic phosphorus increased slowly in both groups, although it was not within the normal range at eight hours. In both groups, it achieved normal values at 24, 48 and 72 hours.The mean electrolyte concentrations did not differ significantly at any measuring point between cows that stood within eight hours of treatment and those that did not. Our results indicate that increasing the dose of calcium administered does not improve the recovery rate of cows with parturient paresis.     

The prophylactic use of vitamin D3 in parturient paresis in the cow in a practice district in eastern Norway. A retrospective investigation.

The prophylactic effect in parturient paresis of an intramuscular injection of 10 million i.u. vitamin D3 one week prior to the expected calving date, was investigated in 84 cows which had previously suffered from parturient paresis. Clinical observations in connection with the development of parturient paresis after injection of vitamin D3 were compared with corresponding observations made on cows within the same population at the previous calving when no vitamin D3 was administered. The incidence of clinical parturient paresis in cows given vitamin D3 was 44.3 per cent. There were no significant differences in the incidence of parturient paresis in cows injected with vitamin D3 during the periods less than 2, 2--4, 5--8 and greater than 8 days before parturition. Average plasma calcium levels (mg/100 ml) before first calcium treatment, results of treatment, and the incidence of retained placenta in vitamin D3 injected cows did not differ significantly from corresponding data for cows with clinical parturient paresis which had not been given vitamin D3 before calving. It is concluded that vitamin D3 does not have any prophylactic effect in parturient paresis in cows in Eastern Norway.     

Lipid mobilization in parturient cows.

The blood levels of calcium, inorganic phosphorus, magnesium, glucose and NEFA were studied in cows at the time around partus. Eight of 16 cows developed hypocalcaemic paresis. Besides hypocalcaemia the paretic cows showed lower levels of inorganic phosphorus and higher levels of glucose and NEFA than non-paretic cows 24 hrs. post partum. It is known that lipolysis is associated with uptake of calcium in adipose tissue. The calcium content in perirenal adipose tissue was however lower in paretic cows than in non-paretic parturient cows and lactating cows slaughtered 3–5 months after calving. The calcium content in omental adipose tissue was about the same in all 3 groups. Despite increased lipolysis the calcium content in adipose tissue is thus not increased in cows suffering from parturient paresis.     

Effect of oral administration of a calcium chloride gel on blood mineral concentrations, parturient disorders, reproductive performance, and milk production of dairy cows with retained fetal membranes.

OBJECTIVE: To assess the effect of oral administration of CaCl2 gel on blood mineral concentrations, parturient disorders, reproductive performance, and milk production of dairy cows with retained fetal membranes (RFM). DESIGN: Randomized field trial. ANIMALS: 20 cows that calved normally and were not treated with CaCl2 gel (group 1), 20 cows with RFM that were treated with CaCl2 gel (group 2), and 20 cows with RFM that were not treated with CaCl2 gel (group 3). PROCEDURE: Group-2 cows were treated orally with CaCl2 gel (54 g of calcium) 24 and 48 hours after parturition. RESULTS: Administration of CaCl2 gel 24 and 48 hours after parturition did not have a significant effect on serum normalized calcium, total calcium, magnesium, or phosphorus concentrations or on incidence of metritis or left displacement of the abomasum, days to first insemination, pregnancy status after first insemination, or milk production. CONCLUSIONS AND CLINICAL RELEVANCE: Administration of CaCl2 gel 24 and 48 hours after parturition did not have significant effect on blood mineral concentrations, parturient disorders, reproductive performance, and milk production in dairy cows with RFM.     

Use of 1alpha-hydroxycholecalciferol in the prevention of bovine parturient paresis.

A synthetic biologically active derivative of vitamin D (350 microgram of 1alpha-hydroxycholecalciferol [1alpha(OH)CC]) was injected into 2 nonlactating 7-year-old Israeli-Friesian cows. Plasma calcium values increased after 24 hours, peaked at 48 hours, and returned to base-line values 120 hours after injection. An injection of 350 microgram of 1alpha(OH)CC was given to 23 parturient-paresis-prone Israeli-Friesian cows from 7 days to 6 hours prepartum; 13 cows were injected once, 6 were injected twice, and 4 were injected 3 times, all at 48-hour intervals. Parturient-paresis-prone cows (n = 23) of the same breed were used as controls. Within 0 to 36 hours postpartum, plasma calcium concentrations were found to be higher in cows injected with 1alpha(OH)CC than in the control cows. The increase was highly significant (P less than 0.01) in cows injected at least twice. None of the cows injected with 1alpha(OH)CC, within 72 to 24 hours prior to calving developed parturient paresis; but 9 of 23 control cows developed parturient paresis. Prior to calving, none of the injected cows developed hypercalcemia and there was no local or systemic clinically detectable signs of toxiosis. When given at the right time prepartum, 1alpha(OH)CC is considered to be an improvement over previous methods of preventing bovine parturient paresis.     

Physiologic effects of administration of interleukin 1 beta in cows.

The immunomodulating polypeptide interleukin 1 beta (IL-1 beta) has been shown to be homologous to osteoclast-activating factor and is capable of stimulating increased osteoclastic bone resorption. This effect prompted an investigation into the potential use of IL-1 beta for prevention of parturient paresis, a disease of dairy cows characterized by hypocalcemia and poor osteoclastic resorption of bone. Six nonpregnant cows were treated with a high dosage of IL-1 beta (166 ng/kg of body weight) every 8 hours for 4 days. The IL-1 beta treatment significantly (P < 0.05) increased urinary hydroxyproline excretion, an index of osteoclast activity, indicating that bone calcium resorption might be stimulated by IL-1 beta treatment of cows. However, IL-1 beta treatment also caused transient fever, inappetence, increased pulse and respiratory rate, and diuresis. The acute, but transient, effect of IL-1 beta treatment was to cause a decrease in plasma calcium and phosphorus concentrations. The pleiotropic effects of IL-1 beta administration negated the positive effects on osteoclastic bone resorption, and indicates that this cytokine may be of minimal benefit for prevention of parturient paresis.     

Prolactin, estradiol, and progesterone changes in paretic and nonparetic cows during the periparturient period

We studied the relationship of serum prolactin, estradiol-17 beta, and progesterone concentrations to plasma calcium, phosphorus, and free hydroxyproline concentrations, as well as to dry matter intake, in 14 aged dairy cows (mean of 4.5 parities), 7 of which became paretic, from 28 days before to 4 days after calving. Plasma calcium and phosphorus concentrations and dry matter intake decreased more at parturition in paretic cows than in nonparetic cows. Prolactin concentrations were not different between paretic and nonparetic cows, but were variable. Concentrations of estradiol were higher in paretic cows from 15 to 5 days before parturition, whereas hydroxyproline concentration was lower in paretic cows on days 10 through 3 before parturition. Progesterone concentration was lower in paretic cows and decreased earlier at parturition, compared with that in nonparetic cows. The findings suggested that high estradiol concentrations in late pregnancy inhibit bone resorption and predispose aged cows to parturient paresis. The earlier decrease in progesterone concentration at parturition and lower concentrations throughout late pregnancy might have contributed to the greater inappetence in paretic cows at parturition. The importance of prolactin in the pathogenesis of parturient paresis is not clear.     

The effect of intravenous magnesium hypophosphite in calcium borogluconate solution on the serum concentration of inorganic phosphorus in healthy cows

The goal of this study was to determine the effect of intravenous (IV) administration of phosphite on the serum concentration of inorganic phosphorus in cows. Twelve clinically healthy cows were divided into four groups of three. All cows received 600 mL of a 40% calcium borogluconate solution; three cows each received this as a rapid (20 min) IV infusion with and without 6% magnesium hypophosphite, and three other cows each received this as a slow IV infusion (8 h) with and without 6% magnesium hypophosphite. Samples of blood were collected for the determination of serum concentrations of calcium, inorganic phosphorus and magnesium before and 10, 20, 40, 60 and 90 min and 2, 3, 4, 5, 6, 7, 8, 24, 48 and 72 h after the start of treatment. The concentration of calcium increased after treatment in all cows but the increase was most rapid in cows that received the rapid infusion. In cows that received the rapid IV infusion containing magnesium hypophosphite, the mean concentration of inorganic phosphorus decreased significantly 3-4 h after treatment compared with initial serum levels. The serum concentration of inorganic phosphorus did not change significantly in cows that received the rapid IV solution without magnesium hypophosphite or the slow IV infusion with or without magnesium hypophosphite. The serum concentration of magnesium increased after treatment in all cows receiving magnesium hypophosphite but remained unchanged in the others. The rapid infusion of calcium borogluconate without magnesium hypophosphite made all three cows anorexic and hypercalcaemic and the slow infusion made 1/3 anorexic. It is concluded that the IV administration of a calcium solution containing magnesium hypophosphite does not increase the serum concentration of inorganic phosphorus.     

Milk fever: a case against polypharmacy solutions.

One hundred and thirty four cases of hypocalcaemia (parturient paresis) between April and Jul 1976 from 72 herds in the UK and Eire were used to compare the response to intravenous treatments with one of three solutions containing calcium salts. Two solutions contained 8 g calcium, one with added magnesium (1.03 g), a third solution contained 6.2 g calcium. The biochemical response obtained 24 hours after successful treatment from all solutions was similar. The clinical response with both 8 g calcium solutions was similar and significantly superior to that obtained with 6.2 g calcium (P less than 0.02 greater than 0.01). More cases (44 per cent) relapsed after treatment with 6.2 g calcium. There was no evidence that the added magnesium to the calcium solution improved the clinical response of parturient paresis cases in this spring claving season, as had been suggested previously. The herds providing these 134 cases had recorded an incidence of 8.04 per cent for parturient paresis in 1975.     

Studies on parturient paresis in dairy cows. V. On the composition and calcium binding capacity of two bovine serum protein fractions, with special regard to parturient paresis

In healthy cows unaffected by imminent or recent calving the protein in serum can directly bind the overwhelming proportion of the bound calcium. In recent calvers this capacity is considerably less. When adding ammonium sulphate to blood serum to 62 % of total saturation a protein fraction precipitates which is mainly albumin. This fraction has a far greater calcium binding capacity than the soluble fraction, which contains most of the serum globulin, and the lowering of this capacity after calving is entirely referable to the former fraction. No difference has been found in these respects between normal cows after calving and cows with parturient paresis.An analysis of 10 amino acids in the two protein fractions described above showed that the amino acid composition of both exhibits differences between recent calvers and cows outside the calving period, and likewise that each of the two fractions differs in composition between healthy cows after calving and cows with parturient paresis.     

Parturient paresis and hypocalcemia in ruminant livestock

Parturient paresis (hypocalcemia) is most likely to affect dairy cattle around the time of parturition. It causes progressive neuromuscular dysfunction and flaccid paralysis. Older dairy cows, cows with a history of parturient paresis during a previous lactation, high-producing cows, and cows from the Jersey and Guernsey breeds are at highest risk for developing parturient paresis. Nonparturient hypocalcemia may also occur and is related to events other than parturition, such as severe stress, that temporarily overwhelm the mechanisms of calcium homeostasis. Beef cattle, sheep, and goats are affected less frequently by hypocalcemia than are dairy cows. Because these species are not as stressed for milk production as dairy cattle, nonparturient hypocalcemia makes up a higher proportion of cases in nondairy ruminants. Clinical signs of hypocalcemia in beef cattle, sheep, and goats tend toward hyperesthesia and tetany rather than the classic flaccid paralysis that occurs in dairy cattle with parturient hypocalcemia. Prompt and effective treatment of hypocalcemia helps to reduce the incidence of secondary complications, such as muscle damage or mastitis. The standard treatment regimen of 500 ml of 23 per cent calcium gluconate, administered intravenously, will elicit a favorable response in approximately 75 per cent of recumbent cows within 2 hours of treatment. Relapses following successful initial therapy are common and may be prevented in part by supplementation of intravenous treatment with an additional 500 ml of 23 per cent calcium gluconate administered subcutaneously. Proper nursing care following treatment speeds recovery and reduces the incidence of secondary complications owing to hypocalcemia.     

Effectiveness of calcium chloride in increasing blood calcium concentrations of periparturient dairy cows.

Calcium chloride supplements such as gels and drench were studied to determine their effectiveness for increasing blood serum Ca concentrations in periparturient dairy cows. Multiparous, pregnant Holstein dairy cows (n = 36) were assigned to one of four treatments. After calving, cows in four treatments received basal diet and two doses of either control inert gel (CON), gel containing CaCl2 and vitamins (CVG), gel containing CaCl2 and minerals (CMG), or CaCl2 as drench containing vitamins (CVD). The first dose was given within 2 h after calving and the second dose 12 h after the first dose. Each dose provided .07, 54.5, 56.0, and 33.2 g of elemental Ca in CON, CVG, CMG, and CVD treatments, respectively. Blood samples were collected at 0, 15, 30, 60, 180, and 360 min after each oral dose. The blood serum Ca concentrations were 6.26, 7.56, 6.20, and 5.96 mg/dL during the pretreatment period and deviated -13.5, 7.1, 9.3, and 18.1% from pretreatment levels at 18 h after the first dose in CON, CVG, CMG, and CVD treatments, respectively. The average changes in serum P from pretreatment levels were not different among treatments. Serum Mg concentrations remained below the pretreatment levels in all four treatments. Blood serum beta-hydroxybutyrate during the first 2 wk and milk yields during the first 4 wk of lactation were the same in all treatments. Three cases of clinical milk fever were observed in CON treatment and one case in CVD treatment. The oral supplements of CaCl2 as gel or drench increased the blood Ca levels in periparturient dairy cows. Increased supply of Ca through oral supplements of CaCl2 may prevent milk fever in cows that are marginally hypocalcemic.     

Plasma mineral and energy metabolite concentrations in dairy cows fed an anionic prepartum diet that did or did not have retained fetal membranes after parturition

OBJECTIVE: To compare plasma total calcium, phosphorus, magnesium, nonesterified fatty acids (NEFA), beta hydroxy butyrate (BHB), and glucose concentrations in parturient dairy cows that were fed an anionic prepartum diet between those with and without retained fetal membranes (RFM) at 24 hours after parturition. ANIMALS: 152 Holstein cows that calved during October through December of 1997 PROCEDURE: All cows were fed an anionic prepartum diet. Blood sample was taken within 6 hours after parturition from randomly selected cows. Thirty-nine cows had a diagnosis of RFM at 24 hours after parturition; 113 were not affected with RFM. At calving, body condition score (BCS; 1 [thin] to 5 [obese]), parity, and calving difficulty score were recorded. Plasma calcium, phosphorus, magnesium, NEFA, BHB, and glucose concentrations were compared between cows with or without RFM. RESULTS: Cows with RFM had significantly lower plasma calcium concentration soon after calving, compared with cows without RFM. Cows with a parity of > or = 3 had significantly lower plasma concentrations of calcium and higher concentrations of magnesium, compared with cows with a parity of 1 or 2. Cows with a BCS of > or = 3.25 at calving had significantly higher plasma concentrations of BHB than cows with a BCS of 2.75 to 3.0. Cows with dystocia had significantly higher plasma concentrations of glucose, compared with cows without dystocia. CONCLUSIONS AND CLINICAL RELEVANCE: In parturient cows fed a prepartum anionic diet, those with RFM have lower plasma calcium concentrations than cows without RFM, although this association does not prove a cause-effect relationship.     

Parturient Paresis in the Cow: Serum Ionized Calcium Concentrations Before and after Treatment with Different Calcium Solutions – Classification of Different Degrees of Hypo- and Hypercalcemia

Serum ionized calcium concentrations (Ca_F) were determined in 87 Swedish red-and-white cows and 10 Swedish Friesian cows with clinical signs of parturient paresis. All cows were in the week prior to or after parturition. A classification of the severity of hypocalcemia in terms of serum ionized calcium was devised. Eight cows had normal serum ionized calcium concentrations (Cap 1.06–1.26 mmol/1); 15 had slight (Ca_F 0.80–1.05 mmol/1); 43 a moderate (Ca_F 0.50–0.79 mmol/1), and 31 asevere (Ca_F < 0.50 mmol/1) hypocalcemia.All cows were given 8 or 8.3 g of calcium intravenously. Of 8 normocalcemic cows 7 (87.5 %) reached a maximum posttreatment serum ionized calcium concentration > 1.80 mmol/1 (severe hypercalcemia). This was also found in 13 of 15 (86.7 %) slightly hypocalcemic cows and in 31 of 43 (72.1 %) moderately hypocalcemic cows. In the severe hypocalcemia group 14 of 31 (45.2 %) had maximum posttreatment Cap > 1.80 mmol/1).These findings emphazise the need of a rapid pretreatment evaluation of the degree of hypocalcemia. The present study also underlined the difficulty in predicting serum ionized calcium from serum total calcium concentrations.     

The role of dietary calcium concentration in the use of anionic salts to prevent parturient paresis in dairy cows

The role of dietary calcium concentration during the feeding of anionic salts (AS) was reviewed. Hypocalcaemia is still the major cause of parturient paresis in dairy cows. Feeding AS is an established method for preventing severe hypocalcaemia by activating the calcium metabolism in the last two to three weeks before parturition by inducing a metabolic acidosis. In compensation for this acidosis, the organism increases the concentrations of ionised Ca [Ca2+] in the blood. This increase leads to an increasing excretion of calcium via the urine, which is ensued by an increased calcium absorption in the intestine. The ongoing metabolic acidosis changed the flux of Ca. The size of the Ca pool, however, remained unchanged. As the calcium metabolism is activated by AS, it seems necessary to increase the amount of calcium that is fed to the cows. Several studies examined the impact of different dietary calcium concentrations on the acid-base balance and the calcium metabolism in cows fed anionic salts. The study designs vary concerning the amounts of calcium fed and the use of pregnant or non-pregnant cows. Only one study combined the feeding of AS with a very low amount of calcium, which fell below the daily requirements of pregnant cows in the last three weeks before parturition. In this study, the calcium balance post partum was better in the cows that were administered AS and a high calcium diet. In the other studies, the amount of calcium in the different experimental groups and the difference between the amounts of calcium fed varied greatly. As far as it was monitored in the studies, the calcium concentration of the diet did not have a significant impact on the degree of acidosis induced by AS. In pregnant cows, no significant differences in the calcium concentration in serum or urine occurred before parturition. Some of the researchers found a lower incidence of parturient paresis when cows were fed a combination of AS and a higher amount of calcium, but some other researches did not. Interestingly, the parameters of bone metabolism did not change between experimental groups. According to what is currently known, the feeding of AS to transition cows should not be combined with a dietary calcium concentration that falls below the requirement of cows in this stage of lactation. On the other hand, there is no need to increase the Ca concentration. When AS are used the dietary calcium concentration should be between 9 g and 12 g/kg dry matter. Further research is needed to investigate the role of dietary calcium regarding the use of AS for improving Ca metabolism in dairy cows around parturition.